Search "+Nivolumab"

Positive matches

• 0.294 + - Pembrolizumab
• 0.111 + - PD-1 and PD-L1 inhibitors
• 0.111 + - Melanoma
• 0.111 + - BRAF inhibitor
• 0.111 + - Cancer immunotherapy
• 0.111 + - Ipilimumab
• 0.111 + - Opdivo
• 0.111 + - PD-1
• 0.111 + - BRAF
• 0.048 + - pVAC-Seq
• 0.024 + - January 12
• 0.024 + - November 7
• 0.023 + - Vectibix
• 0.023 + - Anti-GD2 antibodies
• 0.023 + - Erbitux
• 0.023 + - Atezolizumab
• 0.023 + - PD-L1
• 0.023 + - Vemurafenib
• 0.023 + - Cytokine
• 0.023 + - MAPK

Negative matches